Abstract

Genomic instability is a fundamental feature of human cancer often resulting from impaired genome maintenance. In prostate cancer, structural genomic rearrangements are a common mechanism driving tumorigenesis. However, somatic alterations predisposing to chromosomal rearrangements in prostate cancer remain largely undefined. Here, we show that SPOP, the most commonly mutated gene in primary prostate cancer, modulates DNA double strand break (DSB) repair, and that SPOP mutation is associated with genomic instability. In vivo, SPOP mutation results in a transcriptional response consistent with BRCA1 inactivation resulting in impaired homology-directed repair (HDR) of DSB. Furthermore, we found that SPOP mutation sensitizes to DNA damaging therapeutic agents such as PARP inhibitors. These results implicate SPOP as a novel participant in DSB repair, suggest that SPOP mutation drives prostate tumorigenesis in part through genomic instability, and indicate that mutant SPOP may increase response to DNA damaging therapeutics.

Article and author information

Author details

  1. Gunther Boysen

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United Kingdom
    Competing interests
    No competing interests declared.
  2. Christopher E Barbieri

    Department of Urologygy, Weill Cornell Medical College, New York, United States
    Competing interests
    Christopher E Barbieri, A patent (US Patent Application No: 2013/0331,279) has been issued to Weill Medical College of Cornell University on SPOP mutations in prostate cancer; is listed as co-inventor.
  3. Davide Prandi

    Centre for Integrative Biologygy, University of Trento, Trento, Italy
    Competing interests
    No competing interests declared.
  4. Mirjam Blattner

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  5. Sung-Suk Chae

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  6. Arun Dahija

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  7. Srilakshmi Nataraj

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  8. Dennis Huang

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  9. Clarisse Marotz

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  10. Limei Xu

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  11. Julie Huang

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  12. Paola Lecca

    Centre for Integrative Biologygy, University of Trento, Trento, Italy
    Competing interests
    No competing interests declared.
  13. Sagar Chhangawala

    Department of Surgery, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  14. Deli Liu

    Department of Urologygy, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  15. Pengbo Zhou

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  16. Andrea Sboner

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  17. Johann S de Bono

    Division of Clinical Studies, Institute of Cancer Research, London, United Kingdom
    Competing interests
    No competing interests declared.
  18. Francesca Demichelis

    Centre for Integrative Biologygy, University of Trento, Trento, Italy
    Competing interests
    No competing interests declared.
  19. Yariv Houvras

    Department of Surgery, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  20. Mark A Rubin

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    For correspondence
    rubinma@med.cornell.edu
    Competing interests
    Mark A Rubin, A patent (US Patent Application No: 2013/0331,279) has been issued to Weill Medical College of Cornell University on SPOP mutations in prostate cancer; is listed as co-inventor.

Ethics

Animal experimentation: All protocols were performed with prior approval of the WCMC IACUC under protocol 2012-0065.

Copyright

© 2015, Boysen et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 7,235
    views
  • 1,478
    downloads
  • 146
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Gunther Boysen
  2. Christopher E Barbieri
  3. Davide Prandi
  4. Mirjam Blattner
  5. Sung-Suk Chae
  6. Arun Dahija
  7. Srilakshmi Nataraj
  8. Dennis Huang
  9. Clarisse Marotz
  10. Limei Xu
  11. Julie Huang
  12. Paola Lecca
  13. Sagar Chhangawala
  14. Deli Liu
  15. Pengbo Zhou
  16. Andrea Sboner
  17. Johann S de Bono
  18. Francesca Demichelis
  19. Yariv Houvras
  20. Mark A Rubin
(2015)
SPOP mutation leads to genomic instability in prostate cancer
eLife 4:e09207.
https://doi.org/10.7554/eLife.09207

Share this article

https://doi.org/10.7554/eLife.09207

Further reading

    1. Cell Biology
    Laura Childers, Jieun Park ... Michel Bagnat
    Research Article

    Dietary protein absorption in neonatal mammals and fishes relies on the function of a specialized and conserved population of highly absorptive lysosome-rich enterocytes (LREs). The gut microbiome has been shown to enhance absorption of nutrients, such as lipids, by intestinal epithelial cells. However, whether protein absorption is also affected by the gut microbiome is poorly understood. Here, we investigate connections between protein absorption and microbes in the zebrafish gut. Using live microscopy-based quantitative assays, we find that microbes slow the pace of protein uptake and degradation in LREs. While microbes do not affect the number of absorbing LRE cells, microbes lower the expression of endocytic and protein digestion machinery in LREs. Using transgene-assisted cell isolation and single cell RNA-sequencing, we characterize all intestinal cells that take up dietary protein. We find that microbes affect expression of bacteria-sensing and metabolic pathways in LREs, and that some secretory cell types also take up protein and share components of protein uptake and digestion machinery with LREs. Using custom-formulated diets, we investigated the influence of diet and LRE activity on the gut microbiome. Impaired protein uptake activity in LREs, along with a protein-deficient diet, alters the microbial community and leads to an increased abundance of bacterial genera that have the capacity to reduce protein uptake in LREs. Together, these results reveal that diet-dependent reciprocal interactions between LREs and the gut microbiome regulate protein absorption.

    1. Cell Biology
    Rachel Pudlowski, Lingyi Xu ... Jennifer T Wang
    Research Advance

    Centrioles have a unique, conserved architecture formed by three linked, ‘triplet’, microtubules arranged in ninefold symmetry. The mechanisms by which these triplet microtubules are formed remain unclear but likely involve the noncanonical tubulins delta-tubulin and epsilon-tubulin. Previously, we found that human cells lacking delta-tubulin or epsilon-tubulin form abnormal centrioles, characterized by an absence of triplet microtubules, lack of central core protein POC5, and a futile cycle of centriole formation and disintegration (Wang et al., 2017). Here, we show that human cells lacking either TEDC1 or TEDC2 have similar abnormalities. Using ultrastructure expansion microscopy, we observed that mutant centrioles elongate to the same length as control centrioles in G2 phase and fail to recruit central core scaffold proteins. Remarkably, mutant centrioles also have an expanded proximal region. During mitosis, these mutant centrioles further elongate before fragmenting and disintegrating. All four proteins physically interact and TEDC1 and TEDC2 can form a subcomplex in the absence of the tubulins, supporting an AlphaFold Multimer model of the tetramer. TEDC1 and TEDC2 localize to centrosomes and are mutually dependent on each other and on delta-tubulin and epsilon-tubulin for localization. Our results demonstrate that delta-tubulin, epsilon-tubulin, TEDC1, and TEDC2 function together to promote robust centriole architecture, laying the foundation for future studies on the mechanisms underlying the assembly of triplet microtubules and their interactions with centriole structure.